| HGNC Symbol | HGNC Description | Common Name | OMIM | OMIM Phenotype | Nucleotide RefSeq | Protein RefSeq | Entrez | Isoforms | Experiments |
|---|---|---|---|---|---|---|---|---|---|
| ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | ABC1 | 600046 | Tangier disease; High density lipoprotein deficiency, type 2; Tangier disease, variant; High density lipoprotein deficiency; Coronary heart disease in familial hypercholesterolema, protection aganist | NM_005502 | NP_005493 | 19 | 1 | 4 |
| ABCA2 | ATP-binding cassette, sub-family A (ABC1), member 2 | ABC2 | 600047 | NM_001606 | NP_001597 | 20 | 2 | 0 | |
| ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | ABC3 | 601615 | Surfactant deficiency, neonatal | NM_001089 | NP_001080 | 21 | 1 | 1 |
| ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | ABC10 | 601691 | Startgardt disease 1; Macular degeneratons, age-related, 2; Retinitis pigmentosa 19; Cone-rod dystrophy 3; Fundus flavimaculatus | NM_000350 | NP_000341 | 24 | 1 | 1 |
| ABCA5 | ATP-binding cassette, sub-family A (ABC1), member 5 | ABC13 | NM_172232 | NP_758424 | 23461 | 2 | 2 | ||
| ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6 | ABCA6 | NM_080284 | NP_525023 | 23460 | 1 | 1 | ||
| ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | ABCX | 605414 | NM_019112 | NP_061985 | 10347 | 1 | 1 | |
| ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 | ABCA8 | NM_007168 | NP_009099 | 10351 | 1 | 1 | ||
| ABCA9 | ATP-binding cassette, sub-family A (ABC1), member 9 | ABCA9 | NM_080283 | NP_525022 | 10350 | 1 | 1 | ||
| ABCA10 | ATP-binding cassette, sub-family A (ABC1), member 10 | ABCA10 | NM_080282 | NP_525021 | 10349 | 1 | 1 | ||
| ABCA12 | ATP-binding cassette, sub-family A (ABC1), member 12 | LI2 | 607800 | Ichthyosis, lamellar 2 | NM_173076 | NP_775099 | 26154 | 2 | 1 |
| ABCA13 | ATP-binding cassette, sub-family A (ABC1), member 13 | ABCA13 | 607807 | NM_152701 | NP_689914 | 154664 | 1 | 1 | |
| ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | MDR1 | 171050 | Colchicine resistance, Crohn disease | NM_000927 | NP_000918 | 5243 | 1 | 40 |
| ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | MDR3 | 171060 | Cholestasis, familial intrahepatic, of pregnancy; Cholestasis, progressive familial intrahepatic, type III; Cholelithiasis | NM_000443 | NP_000434 | 5244 | 3 | 28 |
| ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | ABCB5 | 611785 | NM_178559 | NP_848654 | 340273 | 1 | 1 | |
| ABCB6 | ATP-binding cassette, sub-family B (MDR/TAP), member 6 | ABC14 | 605452 | NM_005689 | NP_005680 | 10058 | 1 | 1 | |
| ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | ABC7 | 300135 | Anemia, sideroblastic, and spinocerebellar ataxia | NM_004299 | NP_004290 | 22 | 1 | 1 |
| ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | MABC1 | 605464 | NM_007188 | NP_009119 | 11194 | 1 | 1 | |
| ABCB9 | ATP-binding cassette, sub-family B (MDR/TAP), member 9 | TAPL | 605453 | NM_019625 | NP_062571 | 23457 | 3 | 1 | |
| ABCB10 | ATP-binding cassette, sub-family B (MDR/TAP), member 10 | M-ABC2 | 605454 | NM_012089 | NP_036221 | 23456 | 1 | 1 | |
| ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | BSEP | 603201 | Progressive intrahepatic cholestasis-2 | NM_003742 | NP_003733 | 8647 | 1 | 27 |
| ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | MRP1 | 158343 | NM_004996 | NP_004987 | 4363 | 5 | 30 | |
| ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | MRP2 | 601107 | Dubin-Johnson syndrome | NM_000392 | NP_000383 | 1244 | 1 | 31 |
| ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | MRP3 | 604323 | NM_003786 | NP_003777 | 8714 | 2 | 32 | |
| ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | MRP4 | 605250 | NM_005845 | NP_005836 | 10257 | 2 | 30 | |
| ABCC5 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | MRP5 | 605251 | NM_005688 | NP_005679 | 10057 | 2 | 27 | |
| ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | MRP6 | 603234 | Pseudoxanthoma elasticum, autosomal dominant; Pseudoxanthoma elasticum, autosomal recessive; Pseudoxanthoma elasticum, sporadic | NM_001171 | NP_001162 | 368 | 2 | 22 |
| ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | SUR1 | 600509 | Persistent Hyperinsulinemic Hypoglycemia of Infancy; Persistent Hyperinsnulinemic Hypoglycemia of Infancy due to Focal Adenomatous Hyperplasia | NM_000352 | NP_000343 | 6833 | 1 | 1 |
| ABCC9 | ATP-binding cassette, sub-family C (CFTR/MRP), member 9 | SUR2 | 601439 | cardiomyopathy, dilated with ventricular tachycardia | NM_005691 | NP_005682 | 10060 | 3 | 1 |
| ABCC10 | ATP-binding cassette, sub-family C (CFTR/MRP), member 10 | ABCC10 | NM_033450 | NP_258261 | 89845 | 1 | 0 | ||
| ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | ABCC11 | 607040 | NM_032583 | NP_115972 | 85320 | 3 | 1 | |
| ABCC12 | ATP-binding cassette, sub-family C (CFTR/MRP), member 12 | MRP9 | 607041 | NM_033226 | NP_150229 | 94160 | 1 | 0 | |
| ABCC13 | ATP-binding cassette, sub-family C (CFTR/MRP), member 13 | PRED6 | 608835 | NR_003087 | 150000 | 2 | 1 | ||
| ABCD1 | ATP-binding cassette, sub-family D (ALD), member 1 | ALD | 300371 | Adrenoleukodystrophy; Addison disease; Adrenomyeloneuropathy | NM_000033 | NP_000024 | 215 | 1 | 0 |
| ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | ABC39 | 601081 | NM_005164 | NP_005155 | 225 | 1 | 2 | |
| ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | ABC43 | 170995 | Zellweger syndrome 2 | NM_002858 | NP_002849 | 5825 | 2 | 1 |
| ABCD4 | ATP-binding cassette, sub-family D (ALD), member 4 | ABC41 | 603214 | NM_005050 | NP_005041 | 5826 | 1 | 1 | |
| ABCE1 | ATP-binding cassette, sub-family E (OABP), member 1 | ABC38 | 601213 | NM_001040876 | NP_001035809 | 6059 | 2 | 0 | |
| ABCF1 | ATP-binding cassette, sub-family F (GCN20), member 1 | ABC27,ABC50 | 603429 | NM_001025091 | NP_001020262 | 23 | 2 | 0 | |
| ABCF2 | ATP-binding cassette, sub-family F (GCN20), member 2 | ABC28 | NM_005692 | NP_005683 | 10061 | 2 | 0 | ||
| ABCF3 | ATP-binding cassette, sub-family F (GCN20), member 3 | ABCF3 | NM_018358 | NP_060828 | 55324 | 1 | 1 | ||
| ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | ABC8 | 603076 | NM_004915 | NP_004906 | 9619 | 6 | 1 | |
| ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | MXR | 603756 | NM_004827 | NP_004818 | 9429 | 1 | 16 | |
| ABCG4 | ATP-binding cassette, sub-family G (WHITE), member 4 | WHITE2 | 607784 | NM_022169 | NP_071452 | 64137 | 1 | 1 | |
| ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 (sterolin 1) | ABCG5 | 605459 | Sitosterolemia | NM_022436 | NP_071881 | 64240 | 1 | 1 |
| ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 (sterolin 2) | ABCG8 | 605460 | Sitosterolemia | NM_022437 | NP_071882 | 64241 | 1 | 1 |
| AQP4 | 600308 | NM_001650 | NP_001641 | 361 | 2 | 6 | |||
| ATP7A | ATPase, Cu++ transporting, alpha polypeptide (Menkes syndrome) | ATP7A | 300011 | Menkes disease, mild; Occipital horn syndrome; Cutis laxa, neonatal; Menkes disease; Menkes disease, copper-replacement responsive | NM_000052 | NP_000043 | 538 | 1 | 0 |
| ATP7B | ATPase, Cu++ transporting, beta polypeptide (Wilson disease) | ATP7B | 606882 | Wilson disease | NM_000053 | NP_000044 | 540 | 2 | 0 |
| ATP8B1 | ATPase, Class I, type 8B, member 1 | FIC1 | 602397 | Cholestasis, benign recurrent intrahepatic; Cholestasis, progressive familial intrahepatic-1; Byler disease | NM_005603 | NP_005594 | 5205 | 1 | 24 |
| CFTR | cystic fibrosis transmembrane conductance regulator, ATP-binding cassette (sub-family C, member 7) | CFTR | 602421 | cystic fibrosis | NM_000492 | NP_000483 | 1080 | 1 | 0 |
| HTR2A | 182135 | NM_000621 | NP_000612 | 3356 | 1 | 0 | |||
| HTR2C | 312861 | NM_000868 | NP_000859 | 3358 | 1 | 0 | |||
| HTR3B | 604654 | NM_006028 | NP_006019 | 9177 | 1 | 0 | |||
| MAOA | 309850 | NM_000240 | NP_000231 | 4128 | 1 | 0 | |||
| NR1I2 | nuclear receptor subfamily 1, group I, member 2 (isoform 1) | PXR | 603065 | NM_003889 | NP_003880 | 8856 | 3 | 0 | |
| POR | 124015 | NM_000941 | NP_000932 | 5447 | 1 | 12 | |||
| RHAG | Rh-associated glycoprotein | 180297 | NM_000324 | NP_000315 | 6005 | 1 | 0 | ||
| RHBG | Rh family, B glycoprotein (gene/pseudogene) | 607079 | NM_020407 | NP_065140 | 57127 | 1 | 0 | ||
| RHCG | Rh family, C glycoprotein | 605381 | NM_016321 | NP_057405 | 51458 | 1 | 0 | ||
| SLC1A1 | solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 | EAAC1 | 133550 | NM_004170 | NP_004161 | 6505 | 1 | 0 | |
| SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | EAAT2 | 600300 | Amyotryphic lateral sclerosis | NM_004171 | NP_004162 | 6506 | 1 | 0 |
| SLC1A3 | solute carrier family 1 (glial high affinity glutamate transporter), member 3 | EAAT1 | 600111 | NM_004172 | NP_004163 | 6507 | 1 | 0 | |
| SLC1A4 | solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 | SATT | 600229 | NM_003038 | NP_003029 | 6509 | 1 | 0 | |
| SLC1A5 | solute carrier family 1 (neutral amino acid transporter), member 5 | ASCT2 | 109190 | NM_005628 | NP_005619 | 6510 | 1 | 0 | |
| SLC1A6 | solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | EAAT4 | 600637 | NM_005071 | NP_005062 | 6511 | 1 | 0 | |
| SLC1A7 | solute carrier family 1 (glutamate transporter), member 7 | AAAT | 604471 | NM_006671 | NP_006662 | 6512 | 1 | 0 | |
| SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | GLUT | 138140 | Glucose transport defect, blood-brain barrier | NM_006516 | NP_006507 | 6513 | 1 | 0 |
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | GLUT2 | 138160 | Diabetes mellitus, noninsulin-dependent; Fanconi-bickel syndrome | NM_000340 | NP_000331 | 6514 | 1 | 0 |
| SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | GLUT3 | 138170 | NM_006931 | NP_008862 | 6515 | 1 | 0 | |
| SLC2A3P1 | XR_037100 | 100128062 | 1 | 0 | |||||
| SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 | GLUT4 | 138190 | Diabetes mellitus, noninsulin-dependent | NM_001042 | NP_001033 | 6517 | 1 | 0 |
| SLC2A4RG | 609493 | NM_020062 | NP_064446 | 56731 | 1 | 0 | |||
| SLC2A5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | GLUT5 | 138230 | NM_003039 | NP_003030 | 6518 | 1 | 0 | |
| SLC2A6 | solute carrier family 2 (facilitated glucose transporter), member 6 | GLUT6 | 606813 | NM_017585 | NP_060055 | 11182 | 1 | 0 | |
| SLC2A7 | solute carrier family 2 (facilitated glucose transporter), member 7 | GLUT7 | 610371 | NM_207420 | NP_997303 | 155184 | 1 | 0 | |
| SLC2A8 | solute carrier family 2, (facilitated glucose transporter) member 8 | GLUT8 | 605245 | NM_014580 | NP_055395 | 29988 | 1 | 0 | |
| SLC2A9 | solute carrier family 2 (facilitated glucose transporter), member 9 | GLUT9 | 606142 | NM_001001290 | NP_001001290 | 56606 | 2 | 0 | |
| SLC2A10 | solute carrier family 2 (facilitated glucose transporter), member 10 | GLUT10 | 606145 | NM_030777 | NP_110404 | 81031 | 1 | 0 | |
| SLC2A11 | solute carrier family 2 (facilitated glucose transporter), member 11 | GLUT11 | 610367 | NM_001024938 | NP_001020109 | 66035 | 3 | 0 | |
| SLC2A12 | solute carrier family 2 (facilitated glucose transporter), member 12 | GLUT12 | 610372 | NM_145176 | NP_660159 | 154091 | 1 | 0 | |
| SLC2A13 | solute carrier family 2 (facilitated glucose transporter), member 13 | HMIT | 611036 | NM_052885 | NP_443117 | 114134 | 1 | 0 | |
| SLC2A14 | solute carrier family 2 (facilitated glucose transporter), member 14 | GLUT14 | 611039 | NM_153449 | NP_703150 | 144195 | 1 | 0 | |
| SLC3A1 | solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1 | ATR1 | 104614 | Cystinuria | NM_000341 | NP_000332 | 6519 | 1 | 0 |
| SLC3A2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 | 4F2 | 158070 | NM_001012661 | NP_001012679 | 6520 | 6 | 1 | |
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | CD233 | 109270 | Band 3 memphis; Ovalocytosis, southeast asian; Spherocytosis, hereditarty, due to band 3 tuscaloosa; Hemolytic anemia due to band 3 montefiore; Spherocytosis, hereditary, due to band 3 pargue; Spherocytosis, hereditary, due to band 3 chur; Spherocytosis, | NM_000342 | NP_000333 | 6521 | 1 | 0 |
| SLC4A1AP | 602655 | NM_018158 | NP_060628 | 22950 | 1 | 0 | |||
| SLC4A2 | solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1) | AE2 | 109280 | NM_003040 | NP_003031 | 6522 | 1 | 0 | |
| SLC4A3 | solute carrier family 4, anion exchanger, member 3 | AE3 | 106195 | NM_005070 | NP_00506 | 6508 | 2 | 0 | |
| SLC4A4 | solute carrier family 4, sodium bicarbonate cotransporter, member 4 | KNBC | 603345 | Renal tubular acidosis, proximal, with ocular abnormalities | NM_001098484 | NP_001091954 | 8671 | 3 | 0 |
| SLC4A5 | solute carrier family 4, sodium bicarbonate cotransporter, member 5 | NBC4 | 606757 | NM_021196 | NP_067019 | 57835 | 2 | 0 | |
| SLC4A7 | solute carrier family 4, sodium bicarbonate cotransporter, member 7 | 603353 | NM_003615 | NP_003606 | 9497 | 1 | 0 | ||
| SLC4A8 | solute carrier family 4, sodium bicarbonate cotransporter, member 8 | NBC3 | 605024 | NM_001039960 | NP_001035049 | 9498 | 2 | 0 | |
| SLC4A9 | solute carrier family 4, sodium bicarbonate cotransporter, member 9 | AE4 | 610207 | NM_031467 | NP_113655 | 83697 | 1 | 0 | |
| SLC4A10 | solute carrier family 4, sodium bicarbonate transporter-like, member 10 | SLC4A10 | 605556 | NM_022058 | NP_071341 | 57282 | 1 | 0 | |
| SLC4A11 | solute carrier family 4, sodium bicarbonate transporter-like, member 11 | BTR1 | 610206 | NM_032034 | NP_114423 | 83959 | 1 | 0 | |
| SLC5A1 | solute carrier family 5 (sodium/glucose cotransporter), member 1 | SGLT1 | 182380 | Glucose/galactose malabsorption | NM_000343 | NP_000334 | 6523 | 1 | 15 |
| SLC5A2 | solute carrier family 5 (sodium/glucose cotransporter), member 2 | SGLT2 | 182381 | Renal glucosuria | NM_003041 | NP_003032 | 6524 | 1 | 0 |
| SLC5A3 | solute carrier family 5 (inositol transporters), member 3 | SMIT | 600444 | NM_006933 | NP_008864 | 6526 | 1 | 0 | |
| SLC5A4 | solute carrier family 5 (low affinity glucose cotransporter), member 4 | SGLT3 | NM_014227 | NP_055042 | 6527 | 1 | 0 | ||
| SLC5A5 | solute carrier family 5 (sodium iodide symporter), member 5 | NIS | 601843 | Thyroid hormonogenesis, genetic defect in, I | NM_000453 | NP_000444 | 6528 | 1 | 0 |
| SLC5A6 | solute carrier family 5 (sodium-dependent vitamin transporter),- member 6 | SMVT | 604024 | NM_021095 | NP_066918 | 8884 | 1 | 0 | |
| SLC5A7 | solute carrier family 5 (choline transporter), member 7 | CHT1 | 608761 | NM_021815 | NP_068587 | 60482 | 1 | 0 | |
| SLC5A8 | solute carrier family 5 (iodide transporter), member 8 | AIT | 608044 | NM_145913 | NP_666018 | 160728 | 1 | 0 | |
| SLC5A9 | solute carrier family 5 (sodium/glucose cotransporter), member 9 | SGLT4 | NM_001011547 | NP_001011547 | 200010 | 1 | 0 | ||
| SLC5A10 | solute carrier family 5 (sodium/glucose cotransporter), member 10 | SGLT5 | NM_001042450 | NP_001035915 | 125206 | 2 | 0 | ||
| SLC5A11 | solute carrier family 5 (sodium/glucose cotransporter), member 11 | SGLT6 | 610238 | NM_052944 | NP_443176 | 115584 | 1 | 0 | |
| SLC5A12 | solute carrier family 5 (sodium/glucose cotransporter), member 12 | SLC5A12 | NM_178498 | NP_848593 | 159963 | 1 | 0 | ||
| SLC6A1 | solute carrier family 6 (neurotransmitter transporter, GABA), member 1 | GAT1 | 137165 | NM_003042 | NP_003033 | 6529 | 1 | 13 | |
| SLC6A2 | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | NET | 163970 | Orthostatic intolerance | NM_001043 | NP_001034 | 6530 | 1 | 14 |
| SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | DAT | 126455 | NM_001044 | NP_001035 | 6531 | 1 | 15 | |
| SLC6A4 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | SERT | 182138 | Long/short promoter polymorphism; Obsessive-compulsive disorder, susceptibility to | NM_001045 | NP_001036 | 6532 | 1 | 1 |
| SLC6A5 | solute carrier family 6 (neurotransmitter transporter, glycine), member 5 | GLYT2 | 604159 | NM_004211 | NP_004202 | 9152 | 1 | 1 | |
| SLC6A6 | solute carrier family 6 (neurotransmitter transporter, taurine), member 6 | TAUT | 186854 | NM_001134367 | NP_001127839 | 6533 | 3 | 0 | |
| SLC6A7 | solute carrier family 6 (neurotransmitter transporter, L-proline), member 7 | PROT | 606205 | NM_014228 | NP_055043 | 6534 | 1 | 1 | |
| SLC6A8 | solute carrier family 6 (neurotransmitter transporter, creatine), member 8 | CT1 | 300036 | Creatine deficiency syndrome, X-linked; Mental retardation, X-linked, with seizures, short stature, and midface hypoplasia; Mental retardation, X-linked | NM_005629 | NP_005620 | 6535 | 1 | 0 |
| SLC6A9 | solute carrier family 6 (neurotransmitter transporter, glycine), member 9 | GLYT1 | 601019 | NM_201649 | NP_964012 | 6536 | 3 | 1 | |
| SLC6A11 | solute carrier family 6 (neurotransmitter transporter, GABA), member 11 | GAT3 | 607952 | NM_014229 | NP_055044 | 6538 | 1 | 0 | |
| SLC6A12 | solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 | BGT1 | 603080 | NM_003044 | NP_003035 | 6539 | 3 | 1 | |
| SLC6A13 | solute carrier family 6 (neurotransmitter transporter, GABA), member 13 | NM_016615 | NP_057699 | 6540 | 1 | 0 | |||
| SLC6A14 | solute carrier family 6 (neurotransmitter transporter), member 14 | SLC6A14 | 300444 | NM_007231 | NP_009162 | 11254 | 1 | 1 | |
| SLC6A15 | solute carrier family 6, member 15 | V7-3 | 607971 | NM_018057 | NP_060527 | 55117 | 2 | 1 | |
| SLC6A16 | solute carrier family 6, member 16 | NTT5 | 607972 | NM_014037 | NP_054756 | 28968 | 1 | 0 | |
| SLC6A17 | solute carrier family 6, member 17 | SLC6A17 | 610299 | NM_001010898 | NP_001010898 | 388662 | 1 | 1 | |
| SLC6A18 | solute carrier family 6, member 18 | Xtrp2 | 610300 | NM_182632 | NP_872438 | 348932 | 1 | 1 | |
| SLC6A19 | solute carrier family 6 (neutral amino acid transporter), member 19 | HND | 608893 | Hartnup disorder | NM_001003841 | NP_001003841 | 340024 | 1 | 1 |
| SLC6A20 | solute carrier family 6 (proline IMINO transporter), member 20 | Xtrp3 | 605616 | NM_020208 | NP_064593 | 54716 | 2 | 0 | |
| SLC7A1 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | CAT1 | 104615 | NM_003045 | NP_003036 | 6541 | 1 | 0 | |
| SLC7A2 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 | CAT2 | 601872 | NM_001008539 | NP_001008539 | 6542 | 2 | 0 | |
| SLC7A3 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 | ATRC3,CAT3 | 300443 | NM_001048164 | NP_001041629 | 84889 | 2 | 0 | |
| SLC7A4 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 4 | CAT4 | 603752 | NM_004173 | NP_004164 | 6545 | 1 | 0 | |
| SLC7A5 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 | LAT1-5 | 600182 | NM_003486 | NP_003477 | 8140 | 1 | 13 | |
| SLC7A6 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 6 | SLC7A6 | 605641 | NM_001076785 | NP_001070253 | 9057 | 2 | 0 | |
| SLC7A6OS | solute carrier family 7, member 6 opposite strand | NM_032178 | NP_115554 | 84138 | 1 | 0 | |||
| SLC7A7 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 | LAT1-7 | 603593 | Lysinuric protein intolerance | NM_001126105 | NP_001119577 | 9056 | 3 | 9 |
| SLC7A8 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 | SLC7A8 | 604235 | NM_012244 | NP_036376 | 23428 | 2 | 0 | |
| SLC7A9 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 | SLC7A9 | 604144 | Cystinuria, type II; Cystinuria, type III; Cystinuria, type II or III | NM_001126335 | NP_001119807 | 11136 | 2 | 0 |
| SLC7A10 | solute carrier family 7, (neutral amino acid transporter, y+ system) member 10 | SLC7A10 | 607959 | NM_019849 | NP_062823 | 56301 | 1 | 0 | |
| SLC7A11 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | SLC7A11 | 607933 | NM_014331 | NP_055146 | 23657 | 1 | 1 | |
| SLC7A13 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 13 | AGT1 | NM_138817 | NP_620172 | 157724 | 1 | 0 | ||
| SLC7A14 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 | NM_020949 | NP_066000 | 57709 | 1 | 0 | |||
| SLC8A1 | solute carrier family 8 (sodium/calcium exchanger), member 1 | NCX1 | 182305 | NM_001112800 | NP_001106271 | 6546 | 4 | 0 | |
| SLC8A2 | solute carrier family 8 (sodium-calcium exchanger), member 2 | NCX2 | 601901 | NM_015063 | NP_055878 | 6543 | 1 | 0 | |
| SLC8A3 | solute carrier family 8 (sodium-calcium exchanger), member 3 | NCX3 | 607991 | NM_033262 | NP_150287 | 6547 | 6 | 0 | |
| SLC9A1 | solute carrier family 9 (sodium/hydrogen exchanger), isoform 1 (antiporter, Na+/H+, amiloride sensitive) | NHE1 | 107310 | NM_003047 | NP_003038 | 6548 | 1 | 0 | |
| SLC9A2 | solute carrier family 9 (sodium/hydrogen exchanger), isoform 2 | NHE2 | 600530 | NM_003048 | NP_003039 | 6549 | 1 | 0 | |
| SLC9A3 | solute carrier family 9 (sodium/hydrogen exchanger), isoform 3 | NHE3 | 182307 | NM_004174 | NP_004165 | 6550 | 1 | 1 | |
| SLC9A3P | 6551 | 0 | |||||||
| SLC9A3R1 | 604990 | NM_004252 | NP_004243 | 9368 | 1 | 0 | |||
| SLC9A3R2 | 606553 | NM_001130012 | NP_001123484 | 9351 | 2 | 0 | |||
| SLC9A4 | solute carrier family 9 (sodium/hydrogen exchanger), isoform 4 | NHE4 | 600531 | NM_001011552 | NP_001011552 | 389015 | 1 | 0 | |
| SLC9A5 | solute carrier family 9 (sodium/hydrogen exchanger), isoform 5 | NHE5 | 600477 | NM_004594 | NP_004585 | 6553 | 1 | 0 | |
| SLC9A6 | solute carrier family 9 (sodium/hydrogen exchanger), isoform 6 | NHE6 | 300231 | NM_001042537 | NP_001036002 | 10479 | 2 | 0 | |
| SLC9A7 | solute carrier family 9 (sodium/hydrogen exchanger), isoform 7 | NHE7 | 300368 | NM_032591 | NP_115980 | 84679 | 1 | 0 | |
| SLC9A8 | solute carrier family 9 (sodium/hydrogen exchanger), isoform 8 | NHE8 | NM_015266 | NP_056081 | 23315 | 1 | 0 | ||
| SLC9A9 | solute carrier family 9 (sodium/hydrogen exchanger), isoform 9 | NHE9 | 608396 | NM_173653 | NP_775924 | 285195 | 1 | 0 | |
| SLC9A10 | solute carrier family 9, isoform 10 | SLC9A10 | NM_183061 | NP_898884 | 285335 | 1 | 0 | ||
| SLC9A11 | solute carrier family 9, isoform 11 | SLC9A11 | NM_178527 | NP_848622 | 284525 | 1 | 0 | ||
| SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | SBAT1,NTCP | 182396 | NM_003049 | NP_003040 | 6554 | 1 | 1 | |
| SLC10A2 | solute carrier family 10 (sodium/bile acid cotransporter family), member 2 | SBAT2 | 601295 | Bile acid malabsorption, primary | NM_000452 | NP_000443 | 6555 | 1 | 0 |
| SLC10A3 | solute carrier family 10 (sodium/bile acid cotransporter family), member 3 | P3 | 312090 | NM_019848 | NP_062822 | 8273 | 1 | 0 | |
| SLC10A4 | solute carrier family 10 (sodium/bile acid cotransporter family), member 4 | SLC10A4 | NM_152679 | NP_689892 | 201780 | 1 | 0 | ||
| SLC10A5 | solute carrier family 10 (sodium/bile acid cotransporter family), member 5 | P5 | NM_001010893 | NP_001010893 | 347051 | 1 | 0 | ||
| SLC10A6 | solute carrier family 10 (sodium/bile acid cotransporter family), member 6 | NM_197965 | NP_932069 | 345274 | 1 | 0 | |||
| SLC10A7 | solute carrier family 10 (sodium/bile acid cotransporter family), member 7 | 611459 | NM_032128 | NP_115504 | 84068 | 2 | 0 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | NRAMP1 | 600266 | NM_000578 | NP_000569 | 6556 | 1 | 11 | |
| SLC11A2 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 | DMT1 | 600523 | NM_000617 | NP_000608 | 4891 | 1 | 14 | |
| SLC12A1 | solute carrier family 12 (sodium/potassium/chloride transporters), member 1 | SLC12A1 | 600839 | Bartter syndrome, antenatal, type 1 | NM_000338 | NP_000329 | 6557 | 1 | 0 |
| SLC12A2 | solute carrier family 12 (sodium/potassium/chloride transporters), member 2 | BSC | 600840 | NM_001046 | NP_001037 | 6558 | 1 | 0 | |
| SLC12A3 | solute carrier family 12 (sodium/chloride transporters), member 3 | TSC | 600968 | Gitelman syndrome | NM_000339 | NP_000330 | 6559 | 3 | 1 |
| SLC12A4 | solute carrier family 12 (potassium/chloride transporters), member 4 | KCC1 | 604119 | NM_005072 | NP_005063 | 6560 | 1 | 0 | |
| SLC12A5 | solute carrier family 12, (potassium-chloride transporter) member 5 | KCC2 | 606726 | NM_001134771 | NP_001128243 | 57468 | 2 | 0 | |
| SLC12A6 | solute carrier family 12 (potassium/chloride transporters), member 6 | KCC3 | 604878 | Agenesis of the corpus callosum with peripheral neuropathy | NM_001042494 | NP_001035959 | 9990 | 6 | 0 |
| SLC12A7 | solute carrier family 12 (potassium/chloride transporters), member 7 | KCC4 | 604879 | NM_006598 | NP_006589 | 10723 | 1 | 0 | |
| SLC12A8 | solute carrier family 12 (potassium/chloride transporters), member 8 | CCC9 | 611316 | NM_024628 | NP_078904 | 84561 | 1 | 0 | |
| SLC12A9 | solute carrier family 12 (potassium/chloride transporters), member 9 | CIP1 | NM_020246 | NP_064631 | 56996 | 1 | 0 | ||
| SLC13A1 | solute carrier family 13 (sodium/sulfate symporters), member 1 | NAS1 | 606193 | NM_022444 | NP_071889 | 6561 | 1 | 14 | |
| SLC13A2 | solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | NaDC1 | 604148 | NM_003984 | NP_003975 | 9058 | 1 | 12 | |
| SLC13A3 | solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | NADC3 | 606411 | NM_022829 | NP_073740 | 64849 | 2 | 0 | |
| SLC13A4 | solute carrier family 13 (sodium/sulfate symporters), member 4 | SUT1 | 604309 | NM_012450 | NP_036582 | 26266 | 1 | 0 | |
| SLC13A5 | solute carrier family 13 (sodium-dependent citrate transporter), member 5 | NACT | 608305 | NM_177550 | NP_808218 | 284111 | 1 | 0 | |
| SLC14A1 | solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | UT-B1 | 111000 | Kidd blood polymorphism, Jk; JK-null variant; Jk-null variant, finnish type | NM_001128588 | NP_001122060 | 6563 | 2 | 0 |
| SLC14A2 | solute carrier family 14 (urea transporter), member 2 | UT2 | 601611 | NM_007163 | NP_009094 | 8170 | 1 | 0 | |
| SLC15A1 | solute carrier family 15 (oligopeptide transporter), member 1 | PEPT1 | 600544 | NM_005073 | NP_005064 | 6564 | 1 | 19 | |
| SLC15A2 | oligopeptide transporter, kidney isoform (peptide transporter 2) (kidney H+/peptide cotransporter) | PEPT2 | 602339 | NM_021082 | NP_066568 | 6565 | 1 | 22 | |
| SLC15A3 | solute carrier family 15, member 3 | SLC15A3 | 610408 | NM_016582 | NP_057666 | 51296 | 1 | 0 | |
| SLC15A4 | solute carrier family 15, member 4 | SLC15A4 | NM_145648 | NP_663623 | 121260 | 1 | 0 | ||
| SLC15A5 | solute carrier family 15, member 5 | XM_001129090 | XP_001129090 | 729025 | 1 | 0 | |||
| SLC16A1 | solute carrier family 16 (monocarboxylic acid transporters), member 1 | MCT1 | 600682 | NM_003051 | NP_003042 | 6566 | 1 | 1 | |
| SLC16A2 | solute carrier family 16 (monocarboxylic acid transporters), member 2 | MCT8 | 300095 | Monocarboxylate transporter 8 deficiency | NM_006517 | NP_006508 | 6567 | 1 | 0 |
| SLC16A3 | solute carrier family 16 (monocarboxylic acid transporters), member 3 | MCT3 | 603877 | NM_001042422 | NP_001035887 | 9123 | 3 | 0 | |
| SLC16A4 | solute carrier family 16 (monocarboxylic acid transporters), member 4 | MCT4 | 603878 | NM_004696 | NP_004687 | 9122 | 1 | 0 | |
| SLC16A5 | solute carrier family 16 (monocarboxylic acid transporters), member 5 | MCT5 | 603879 | NM_004695 | NP_004686 | 9121 | 1 | 0 | |
| SLC16A6 | solute carrier family 16 (monocarboxylic acid transporters), member 6 | MCT6 | 603880 | NM_004694 | NP_004685 | 9120 | 1 | 0 | |
| SLC16A7 | solute carrier family 16 (monocarboxylic acid transporters), member 7 | MCT2 | 603654 | NM_004731 | NP_004722 | 9194 | 1 | 0 | |
| SLC16A8 | solute carrier 16 (monocarboxylic acid transporters), member 8 | MCT3 | 610409 | NM_013356 | NP_037488 | 23539 | 1 | 0 | |
| SLC16A9 | solute carrier family 16 (monocarboxylic acid transporters), member 9 | SLC16A9 | NM_194298 | NP_919274 | 220963 | 1 | 0 | ||
| SLC16A10 | solute carrier family 16 (monocarboxylic acid transporters), member 10 | TAT1 | 607550 | NM_018593 | NP_061063 | 117247 | 1 | 0 | |
| SLC16A11 | solute carrier family 16 (monocarboxylic acid transporters), member 11 | SLC16A11 | NM_153357 | NP_699188 | 162515 | 1 | 0 | ||
| SLC16A12 | solute carrier family 16, member 12 (monocarboxylic acid transporter 12) | 611910 | NM_213606 | NP_998771 | 387700 | 1 | 0 | ||
| SLC16A13 | solute carrier family 16 (monocarboxylic acid transporters), member 13 | SLC16A13 | NM_201566 | NP_963860 | 201232 | 1 | 0 | ||
| SLC16A14 | solute carrier family 16 (monocarboxylic acid transporters), member 14 | SLC16A14 | NM_152527 | NP_689740 | 151473 | 1 | 0 | ||
| SLC17A1 | solute carrier family 17 (sodium phosphate), member 1 | NAPI1 | 182308 | NM_005074 | NP_005065 | 6568 | 1 | 1 | |
| SLC17A2 | solute carrier family 17 (sodium phosphate), member 2 | NPT3 | 611049 | NM_005835 | NP_005826 | 10246 | 1 | 1 | |
| SLC17A3 | solute carrier family 17 (sodium phosphate), member 3 | NPT4 | 611034 | NM_001098486 | NP_001091956 | 10786 | 2 | 1 | |
| SLC17A4 | solute carrier family 17 (sodium phosphate), member 4 | KAIA2138 | 604216 | NM_005495 | NP_005486 | 10050 | 1 | 1 | |
| SLC17A5 | solute carrier family 17 (anion/sugar transporter), member 5 | SLC17A5 | 604322 | Salla disease; Infantile sialic acid storage disorder | NM_012434 | NP_036566 | 26503 | 1 | 0 |
| SLC17A6 | solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 | VGLUT2 | 607563 | NM_020346 | NP_065079 | 57084 | 1 | 1 | |
| SLC17A7 | brain-specific Na-dependent inorganic phosphate cotransport | VGLUT1 | 605208 | NM_020309 | NP_064705 | 57030 | 1 | 4 | |
| SLC17A8 | solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 | VGLUT3 | 607557 | NM_139319 | NP_647480 | 246213 | 1 | 13 | |
| SLC17A9 | solute carrier family 17, member 9 | 612107 | NM_022082 | NP_071365 | 63910 | 1 | 0 | ||
| SLC18A1 | solute carrier family 18 (vesicular monoamine), member 1 | VMAT1 | 193002 | NM_003053 | NP_003044 | 6570 | 4 | 13 | |
| SLC18A2 | solute carrier family 18 (vesicular monoamine), member 2 | VMAT2 | 193001 | NM_003054 | NP_003045 | 6571 | 1 | 11 | |
| SLC18A3 | solute carrier family 18 (vesicular acetylcholine), member 3 | VACHT | 600336 | NM_003055 | NP_003046 | 6572 | 1 | 4 | |
| SLC19A1 | solute carrier family 19 (folate transporter), member 1 | RFC1 | 600424 | NM_194255 | NP_919231 | 6573 | 1 | 4 | |
| SLC19A2 | solute carrier family 19 (thiamine transporter), member 2 | TRMA | 603941 | Thiamine-responsive megaloblastic anemia syndrome | NM_006996 | NP_008927 | 10560 | 1 | 1 |
| SLC19A3 | solute carrier family 19, member 3 | SLC19A3 | 606152 | NM_025243 | NP_079519 | 80704 | 1 | 0 | |
| SLC20A1 | solute carrier family 20 (phosphate transporter), member 1 | SLC20A1 | 137570 | NM_005415 | NP_005406 | 6574 | 1 | 0 | |
| SLC20A2 | solute carrier family 20 (phosphate transporter), member 2 | SLC20A2 | 158378 | NM_006749 | NP_006740 | 6575 | 1 | 0 | |
| SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 | OCT1 | 602607 | NM_003057 | NP_003048 | 6580 | 2 | 11 | |
| SLC22A2 | solute carrier family 22 (organic cation transporter), member 2 | OCT2 | 602608 | NM_003058 | NP_003049 | 6582 | 1 | 12 | |
| SLC22A3 | solute carrier family 22 (extraneuronal monoamine transporter), member 3 | OCT3 | 604842 | NM_021977 | NP_068812 | 6581 | 1 | 11 | |
| SLC22A4 | solute carrier family 22 (organic cation transporter), member 4 | OCTN1 | 604190 | Rheumatoid arthritis, susceptibility to; Crohn disease, susceptibility to | NM_003059 | NP_003050 | 6583 | 1 | 11 |
| SLC22A5 | solute carrier family 22 (organic cation transporter), member 5 | OCTN2 | 603377 | Carnitine deficiency, systemic primary; Crohn disease, susceptibility to | NM_003060 | NP_003051 | 6584 | 1 | 12 |
| SLC22A6 | solute carrier family 22 (organic anion transporter), member 6 | OAT1 | 607582 | NM_004790 | NP_004781 | 9356 | 4 | 11 | |
| SLC22A7 | solute carrier family 22 (organic anion transporter), member 7 | OAT2 | 604995 | NM_006672 | NP_006663 | 10864 | 2 | 13 | |
| SLC22A8 | solute carrier family 22 (organic anion transporter), member 8 | OAT3 | 607581 | NM_004254 | NP_004245 | 9376 | 1 | 10 | |
| SLC22A9 | solute carrier family 22 (organic anion/cation transporter), member 9 | OAT4 | 607579 | NM_080866 | NP_543142 | 114571 | 1 | 1 | |
| SLC22A10 | 607580 | NM_001039752 | NP_001034841 | 387775 | 1 | 1 | |||
| SLC22A11 | solute carrier family 22 (organic anion/cation transporter), member 11 | OAT4 | 607097 | NM_018484 | NP_060954 | 55867 | 1 | 13 | |
| SLC22A12 | solute carrier family 22 (organic anion/cation transporter), member 12 | OAT4L | 607096 | Renal hypouricemia | NM_144585 | NP_653186 | 116085 | 2 | 1 |
| SLC22A13 | solute carrier family 22 (organic cation transporter), member 13 | OCTL1 | 604047 | NM_004256 | NP_004247 | 9390 | 1 | 1 | |
| SLC22A14 | solute carrier family 22 (organic cation transporter), member 14 | OCTL2 | 604048 | NM_004803 | NP_004794 | 9389 | 1 | 1 | |
| SLC22A15 | solute carrier family 22 (organic cation transporter), member 15 | FLIPT1 | 608275 | NM_018420 | NP_060890 | 55356 | 1 | 0 | |
| SLC22A16 | solute carrier family 22 (organic cation transporter), member 16 | FLIPT2 | 608276 | NM_033125 | NP_149116 | 85413 | 1 | 1 | |
| SLC22A17 | solute carrier family 22 (organic cation transporter), member 17 | BOCT | 611461 | NM_020372 | NP_065105 | 51310 | 2 | 1 | |
| SLC22A18 | solute carrier family 22 (organic cation transporter), member 18 | HET | 602631 | Breast cancer; Rhambdomyosarcoma; Lung cancer, somatic | NM_002555 | NP_002546 | 5002 | 2 | 1 |
| SLC22A18AS | 603240 | NM_007105 | NP_009036 | 5003 | 1 | 0 | |||
| SLC22A20 | solute carrier family 22, member 20 | 611696 | NM_001004326 | NP_001004326 | 440044 | 1 | 0 | ||
| SLC22A23 | solute carrier family 22, member 23 | 611697 | NM_015482 | NP_056297 | 63027 | 2 | 0 | ||
| SLC22A24 | solute carrier family 22, member 24 | 611698 | NM_001136506 | NP_001129978 | 283238 | 2 | 0 | ||
| SLC22A25 | solute carrier family 22, member 25 | 610792 | NM_199352 | NP_955384 | 387601 | 1 | 0 | ||
| SLC23A1 | solute carrier family 23 (nucleobase transporters), member 1 | SVCT1 | 603790 | NM_005847 | NP_005838 | 9963 | 2 | 0 | |
| SLC23A2 | solute carrier family 23 (nucleobase transporters), member 2 | SVCT2 | 603791 | NM_005116 | NP_005107 | 9962 | 2 | 0 | |
| SLC23A3 | solute carrier family 23 (nucleobase transporters), member 3 | SVCT3 | NM_144712 | NP_653313 | 151295 | 1 | 0 | ||
| SLC23A4 | 641842 | 0 | |||||||
| SLC24A1 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 | NCKX | 603617 | NM_004727 | NP_004718 | 9187 | 1 | 0 | |
| SLC24A2 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 | NCKX2 | 609838 | NM_020344 | NP_065077 | 25769 | 1 | 0 | |
| SLC24A3 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 | NCKX3 | 609839 | NM_020689 | NP_065740 | 57419 | 1 | 0 | |
| SLC24A4 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 | NCKX4 | 609840 | NM_153646 | NP_705932 | 123041 | 3 | 0 | |
| SLC24A5 | solute carrier family 24, member 5 | NCKX5 | 609802 | NM_205850 | NP_995322 | 283652 | 1 | 0 | |
| SLC24A6 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 6 | NCKX6 | 609841 | NM_024959 | NP_079235 | 80024 | 1 | 0 | |
| SLC25A1 | solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 | CTP,SLC20A3 | 190315 | NM_005984 | NP_005975 | 6576 | 1 | 0 | |
| SLC25A2 | solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2 | ORNT2 | 608157 | NM_031947 | NP_114153 | 83884 | 1 | 0 | |
| SLC25A3 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 | PHC | 600370 | NM_002635 | NP_002626 | 5250 | 3 | 0 | |
| SLC25A4 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | ANT1 | 103220 | Progressive external ophthalmoplegia with mitochondrial deletions, autosomal dominant | NM_001151 | NP_001142 | 291 | 1 | 0 |
| SLC25A5 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 | ANT2 | 300150 | NM_001152 | NP_001143 | 292 | 1 | 0 | |
| SLC25A6 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 6 | NCKX6 | 403000 | NM_001636 | NP_001627 | 293 | 1 | 0 | |
| SLC25A7 | uncoupling protein 1 (mitochondrial, proton carrier) | UCP1 | 113730 | UCP1 polymorphism | NM_021833 | NP_068605 | 7350 | 1 | 0 |
| SLC25A8 | uncoupling protein 2 (mitochondrial, proton carrier) | UCP2 | 601693 | Obesity, susceptibility to | NM_003355 | NP_003346 | 7351 | 1 | 0 |
| SLC25A9 | uncoupling protein 3 (mitochondrial, proton carrier) | UCP3 | 602044 | UCP3 polymorphism G/A; Obesity, severe, and type II diabetes; UCP3 polymprphism, exon6 splice donor junction | NM_003356 | NP_003347 | 7352 | 2 | 0 |
| SLC25A10 | solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 | DIC | 606794 | NM_012140 | NP_036272 | 1468 | 1 | 0 | |
| SLC25A11 | solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 | OGC,SLC20A4 | 604165 | NM_003562 | NP_003553 | 8402 | 1 | 0 | |
| SLC25A12 | solute carrier family 25 (mitochondrial carrier, Aralar), member 12 | ARALAR | 603667 | NM_003705 | NP_003696 | 8604 | 1 | 0 | |
| SLC25A13 | solute carrier family 25, member 13 (citrin) | ARALAR2 | 603859 | Cirullinemia, type II, adult-onset | NM_014251 | NP_055066 | 10165 | 1 | 0 |
| SLC25A14 | solute carrier family 25 (mitochondrial carrier, brain), member 14 | UCP5 | 300242 | NM_003951 | NP_003942 | 9016 | 2 | 0 | |
| SLC25A15 | solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 | HHH | 603861 | HHH syndrome | NM_014252 | NP_055067 | 10166 | 1 | 0 |
| SLC25A16 | solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16 | GDA | 139080 | NM_152707 | NP_689920 | 8034 | 1 | 0 | |
| SLC25A17 | solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17 | PMP34 | 606795 | NM_006358 | NP_006349 | 10478 | 1 | 0 | |
| SLC25A18 | solute carrier family 25 (mitochondrial carrier), member 18 | GC2 | 609303 | NM_031481 | NP_113669 | 83733 | 1 | 0 | |
| SLC25A19 | solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19 | DNC | 606521 | Microcephaly, amish type | NM_001126121 | NP_001119593 | 60386 | 3 | 0 |
| SLC25A20 | solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 | CAC | 212138 | Carnitine-acylcarnitine translocase deficiency | NM_000387 | NP_000378 | 788 | 1 | 0 |
| SLC25A21 | solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 | ODC | 607571 | NM_030631 | NP_085134 | 89874 | 1 | 0 | |
| SLC25A22 | solute carrier family 25 (mitochondrial carrier: glutamate), member 22 | GC1 | 609302 | NM_024698 | NP_078974 | 79751 | 1 | 0 | |
| SLC25A23 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 | APC2 | 608746 | NM_024103 | NP_077008 | 79085 | 1 | 0 | |
| SLC25A24 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 | APC1 | 608744 | NM_013386 | NP_037518 | 29957 | 2 | 0 | |
| SLC25A25 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 | MCSC | 608745 | NM_001006641 | NP_001006642 | 114789 | 4 | 0 | |
| SLC25A26 | solute carrier family 25, member 26 | SAMC | 611037 | NM_173471 | NP_775742 | 115286 | 1 | 0 | |
| SLC25A27 | solute carrier family 25, member 27 | UCP4 | NM_004277 | NP_004268 | 9481 | 1 | 0 | ||
| SLC25A28 | solute carrier family 25, member 28 | MRS3/4 | 609767 | NM_031212 | NP_112489 | 81894 | 1 | 0 | |
| SLC25A29 | solute carrier family 25, member 29 | SLC25A29 | NM_001039355 | NP_001034444 | 123096 | 1 | 0 | ||
| SLC25A30 | solute carrier family 25, member 30 | SLC25A30 | 610793 | NM_001010875 | NP_001010875 | 253512 | 1 | 0 | |
| SLC25A31 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 | 610796 | NM_031291 | NP_112581 | 83447 | 1 | 0 | ||
| SLC25A32 | solute carrier family 25, member 32 | 610815 | NM_030780 | NP_110407 | 81034 | 1 | 0 | ||
| SLC25A33 | solute carrier family 25, member 33 | 610816 | NM_032315 | NP_115691 | 84275 | 1 | 0 | ||
| SLC25A34 | solute carrier family 25, member 34 | 610817 | NM_207348 | NP_997231 | 284723 | 1 | 0 | ||
| SLC25A35 | solute carrier family 25, member 35 | 610818 | NM_201520 | NP_958928 | 399512 | 1 | 0 | ||
| SLC25A36 | solute carrier family 25, member 36 | NM_001104647 | NP_001098117 | 55186 | 2 | 0 | |||
| SLC25A37 | solute carrier family 25, member 37 | 610387 | NM_016612 | NP_057696 | 51312 | 1 | 0 | ||
| SLC25A38 | solute carrier family 25, member 38 | 610819 | NM_017875 | NP_060345 | 54977 | 1 | 0 | ||
| SLC25A39 | solute carrier family 25, member 39 | 610820 | NM_016016 | NP_057100 | 51629 | 2 | 0 | ||
| SLC25A40 | solute carrier family 25, member 40 | 610821 | NM_018843 | NP_061331 | 55972 | 1 | 0 | ||
| SLC25A41 | solute carrier family 25, member 41 | 610822 | NM_173637 | NP_775908 | 284427 | 1 | 0 | ||
| SLC25A42 | solute carrier family 25, member 42 | 610823 | NM_178526 | NP_848621 | 284439 | 1 | 0 | ||
| SLC25A43 | solute carrier family 25, member 43 | 300641 | NM_145305 | NP_660348 | 203427 | 1 | 0 | ||
| SLC25A44 | solute carrier family 25, member 44 | 610824 | NM_014655 | NP_055470 | 9673 | 2 | 0 | ||
| SLC25A45 | solute carrier family 25, member 45 | 610825 | NM_182556 | NP_872362 | 283130 | 2 | 0 | ||
| SLC25A46 | solute carrier family 25, member 46 | 610826 | NM_138773 | NP_620128 | 91137 | 1 | 0 | ||
| SLC26A1 | solute carrier family 26 (sulfate transporter), member 1 | SAT1 | 610130 | NM_022042 | NP_071325 | 10861 | 3 | 0 | |
| SLC26A2 | solute carrier family 26 (sulfate transporter), member 2 | DTD | 606718 | Diastrophic dysplasia; Atelosteogenisi, type II; Achondrogensis, type IB; Diastrophic dyplasia, broad bone-platyspondylic variant; Epiphyseal dysplasia, multiple, 4 | NM_000112 | NP_000103 | 1836 | 1 | 0 |
| SLC26A3 | solute carrier family 26, member 3 | CLD | 126650 | Chloride diarrhea, congential, finnish type; Chloride diarrhea, congential | NM_000111 | NP_000102 | 1811 | 1 | 0 |
| SLC26A4 | solute carrier family 26, member 4 | PDS | 605646 | Pendred syndrome; Deafness, autosomal recessive 4; Enlarger vestibular aqueduct | NM_000441 | NP_000432 | 5172 | 1 | 0 |
| SLC26A5 | prestin (motor protein) | PRES | 604943 | NM_198999 | NP_945350 | 375611 | 4 | 0 | |
| SLC26A6 | solute carrier family 26, member 6 | SLC26A6 | 610068 | NM_022911 | NP_075062 | 65010 | 4 | 0 | |
| SLC26A7 | solute carrier family 26, member 7 | SLC26A7 | 608479 | NM_052832 | NP_439897 | 115111 | 2 | 0 | |
| SLC26A8 | solute carrier family 26, member 8 | TAT1 | 608480 | NM_052961 | NP_443193 | 116369 | 2 | 0 | |
| SLC26A9 | solute carrier family 26, member 9 | SLC26A9 | 608481 | NM_052934 | NP_443166 | 115019 | 2 | 0 | |
| SLC26A10 | solute carrier family 26, member 10 | SLC26A10 | NM_133489 | NP_597996 | 65012 | 1 | 0 | ||
| SLC26A11 | solute carrier family 26, member 11 | SLC26A11 | 610117 | NM_173626 | NP_775897 | 284129 | 1 | 0 | |
| SLC27A1 | solute carrier family 27 (fatty acid transporter), member 1 | FATP | 600691 | NM_198580 | NP_940982 | 376497 | 1 | 0 | |
| SLC27A2 | solute carrier family 27 (fatty acid transporter), member 2 | FATP2 | 603247 | NM_003645 | NP_003636 | 11001 | 1 | 0 | |
| SLC27A3 | solute carrier family 27 (fatty acid transporter), member 3 | FATP3 | 604193 | NM_024330 | NP_077306 | 11000 | 1 | 0 | |
| SLC27A4 | solute carrier family 27 (fatty acid transporter), member 4 | FATP4 | 604194 | NM_005094 | NP_005085 | 10999 | 1 | 0 | |
| SLC27A5 | solute carrier family 27 (fatty acid transporter), member 5 | FATP5 | 603314 | NM_012254 | NP_036386 | 10998 | 1 | 0 | |
| SLC27A6 | solute carrier family 27 (fatty acid transporter), member 6 | FATP6 | 604196 | NM_001017372 | NP_001017372 | 28965 | 2 | 0 | |
| SLC28A1 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 | CNT1 | 606207 | NM_004213 | NP_004204 | 9154 | 2 | 16 | |
| SLC28A2 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 | SPNT1 | 606208 | NM_004212 | NP_004203 | 9153 | 1 | 14 | |
| SLC28A3 | concentrative Na+-nucleoside cotransporter | CNT3 | 608269 | NM_022127 | NP_071410 | 64078 | 1 | 19 | |
| SLC29A1 | solute carrier family 29 (nucleoside transporters), member 1 | ENT1 | 602193 | NM_001078174 | NP_001071642 | 2030 | 5 | 12 | |
| SLC29A2 | solute carrier family 29 (nucleoside transporters), member 2 | ENT2 | 602110 | NM_001532 | NP_001523 | 3177 | 1 | 12 | |
| SLC29A3 | solute carrier family 29 (nucleoside transporters), member 3 | ENT3 | NM_018344 | NP_060814 | 55315 | 1 | 1 | ||
| SLC29A4 | solute carrier family 29 (nucleoside transporters), member 4 | ENT4 | 609149 | NM_001040661 | NP_001035751 | 222962 | 2 | 0 | |
| SLC30A1 | solute carrier family 30 (zinc transporter), member 1 | ZNT1 | 609521 | NM_021194 | NP_067017 | 7779 | 1 | 0 | |
| SLC30A2 | solute carrier family 30 (zinc transporter), member 2 | ZNT2 | 609617 | NM_001004434 | NP_001004434 | 7780 | 2 | 0 | |
| SLC30A3 | solute carrier family 30 (zinc transporter), member 3 | ZNT3 | 602878 | NM_003459 | NP_003450 | 7781 | 1 | 0 | |
| SLC30A4 | solute carrier family 30 (zinc transporter), member 4 | ZNT4 | 602095 | NM_013309 | NP_037441 | 7782 | 1 | 0 | |
| SLC30A5 | solute carrier family 30 (zinc transporter), member 5 | ZNT5 | 607819 | NM_022902 | NP_075053 | 64924 | 2 | 0 | |
| SLC30A6 | solute carrier family 30 (zinc transporter), member 6 | ZNT6 | 611148 | NM_017964 | NP_060434 | 55676 | 1 | 0 | |
| SLC30A7 | solute carrier family 30 (zinc transporter), member 7 | ZNT7 | 611149 | NM_133496 | NP_598003 | 148867 | 1 | 0 | |
| SLC30A8 | solute carrier family 30 (zinc transporter), member 8 | ZNT-8 | 611145 | NM_173851 | NP_776250 | 169026 | 1 | 0 | |
| SLC30A9 | solute carrier family 30 (zinc transporter), member 9 | ZNT9 | 604604 | NM_006345 | NP_006336 | 10463 | 1 | 0 | |
| SLC30A10 | solute carrier family 30 (zinc transporter), member 10 | ZNT8,ZnT-10 | 611146 | NM_018713 | NP_061183 | 55532 | 1 | 0 | |
| SLC31A1 | solute carrier family 31 (copper transporters), member 1 | CTR1 | 603085 | NM_001859 | NP_001850 | 1317 | 1 | 5 | |
| SLC31A2 | solute carrier family 31 (copper transporters), member 2 | CTR2 | 603088 | NM_001860 | NP_001851 | 1318 | 1 | 0 | |
| SLC32A1 | solute carrier family 32 (GABA vesicular transporter), member 1 | VGAT | NM_080552 | NP_542119 | 140679 | 1 | 1 | ||
| SLC33A1 | solute carrier family 33 (acetyl-CoA transporter), member 1 | AT1, ACATN | 603690 | NM_004733 | NP_004724 | 9197 | 1 | 0 | |
| SLC34A1 | solute carrier family 34 (sodium phosphate), member 1 | SLC34A1 | 182309 | Urolithiasis, hypophosphatemic; osteoporosis, hypophosphatemic | NM_003052 | NP_003043 | 6569 | 1 | 0 |
| SLC34A2 | solute carrier family 34 (sodium phosphate), member 2 | SLC34A2 | 604217 | NM_006424 | NP_006415 | 10568 | 1 | 0 | |
| SLC34A3 | solute carrier family 34 (sodium phosphate), member 3 | SLC34A3 | 609826 | NM_080877 | NP_543153 | 142680 | 1 | 0 | |
| SLC35A1 | solute carrier family 35 (CMP-sialic acid transporter), member A1 | CST | 605634 | NM_006416 | NP_006407 | 10559 | 1 | 0 | |
| SLC35A2 | solute carrier family 35 (UDP-galactose transporter), member A2 | UGT | 314375 | NM_001032289 | NP_001027460 | 7355 | 3 | 0 | |
| SLC35A3 | solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 | SLC35A3 | 605632 | NM_012243 | NP_036375 | 23443 | 1 | 0 | |
| SLC35A4 | solute carrier family 35, member A4 | MGC2541 | NM_080670 | NP_542401 | 113829 | 1 | 0 | ||
| SLC35A5 | solute carrier family 35, member A5 | FLJ20730 | NM_017945 | NP_060415 | 55032 | 1 | 0 | ||
| SLC35B1 | solute carrier family 35, member B1 | 610790 | NM_005827 | NP_005818 | 10237 | 1 | 0 | ||
| SLC35B2 | solute carrier family 35, member B2 | 610788 | NM_178148 | NP_835361 | 347734 | 1 | 0 | ||
| SLC35B3 | solute carrier family 35, member B3 | 610845 | NM_015948 | NP_057032 | 51000 | 3 | 0 | ||
| SLC35B4 | solute carrier family 35, member B4 | 610923 | NM_032826 | NP_116215 | 84912 | 1 | 0 | ||
| SLC35C1 | solute carrier family 35, member C1 | 605881 | NM_018389 | NP_060859 | 55343 | 3 | 0 | ||
| SLC35C2 | solute carrier family 35, member C2 | NM_015945 | NP_057029 | 51006 | 4 | 0 | |||
| SLC35D1 | solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 | 610804 | NM_015139 | NP_055954 | 23169 | 1 | 0 | ||
| SLC35D2 | solute carrier family 35, member D2 | 609182 | NM_007001 | NP_008932 | 11046 | 1 | 0 | ||
| SLC35D3 | solute carrier family 35, member D3 | 612519 | NM_001008783 | NP_001008783 | 340146 | 1 | 0 | ||
| SLC35E1 | solute carrier family 35, member E1 | NM_024881 | NP_079157 | 79939 | 1 | 0 | |||
| SLC35E2 | solute carrier family 35, member E2 | NM_182838 | NP_878258 | 9906 | 1 | 0 | |||
| SLC35E3 | solute carrier family 35, member E3 | NM_018656 | NP_061126 | 55508 | 1 | 0 | |||
| SLC35F1 | solute carrier family 35, member F1 | NM_001029858 | NP_001025029 | 222553 | 1 | 0 | |||
| SLC35F2 | solute carrier family 35, member F2 | NM_017515 | NP_059985 | 54733 | 1 | 0 | |||
| SLC35F3 | solute carrier family 35, member F3 | NM_173508 | NP_775779 | 148641 | 1 | 0 | |||
| SLC35F4 | solute carrier family 35, member F4 | NM_001080455 | NP_001073924 | 341880 | 1 | 0 | |||
| SLC35F5 | solute carrier family 35, member F5 | NM_025181 | NP_079457 | 80255 | 1 | 0 | |||
| SLC36A1 | solute carrier family 36 (proton/amino acid symporter), member 1 | SLC36A1 | 606561 | NM_078483 | NP_510968 | 206358 | 1 | 0 | |
| SLC36A2 | solute carrier family 36 (proton/amino acid symporter), member 2 | PAT2 | 608331 | NM_181776 | NP_861441 | 153201 | 1 | 0 | |
| SLC36A3 | solute carrier family 36 (proton/amino acid symporter), member 3 | PAT3 | 608332 | NM_181774 | NP_861439 | 285641 | 1 | 0 | |
| SLC36A4 | solute carrier family 36 (proton/amino acid symporter), member 4 | PAT4 | NM_152313 | NP_689526 | 120103 | 1 | 0 | ||
| SLC37A1 | solute carrier family 37 (glycerol-3-phosphate transporter), member 1 | G3PP | 608094 | NM_018964 | NP_061837 | 54020 | 1 | 0 | |
| SLC37A2 | solute carrier family 37 (glycerol-3-phosphate transporter), member 2 | FLJ00171 | NM_198277 | NP_938018 | 219855 | 1 | 0 | ||
| SLC37A3 | solute carrier family 37 (glycerol-3-phosphate transporter), member 3 | MGC32939 | NM_032295 | NP_115671 | 84255 | 2 | 0 | ||
| SLC37A4 | solute carrier family 37 (glycerol-6-phosphate transporter), member 4 | SLC37A4 | 602671 | Glycogen storage disease Ib; Glycogen storage disease Ic | NM_001467 | NP_001458 | 2542 | 1 | 0 |
| SLC38A1 | solute carrier family 38, member 1 | ATA1 | 608490 | NM_001077484 | NP_001070952 | 81539 | 2 | 0 | |
| SLC38A2 | solute carrier family 38, member 2 | SAT2 | 605180 | NM_018976 | NP_061849 | 54407 | 1 | 0 | |
| SLC38A3 | solute carrier family 38, member 3 | G17 | 604437 | NM_006841 | NP_006832 | 10991 | 1 | 0 | |
| SLC38A4 | solute carrier family 38, member 4 | ATA3 | 608065 | NM_018018 | NP_060488 | 55089 | 1 | 0 | |
| SLC38A5 | solute carrier family 38, member 5 | SN2 | 300649 | NM_033518 | NP_277053 | 92745 | 1 | 0 | |
| SLC38A6 | solute carrier family 38, member 6 | NAT-1 | NM_153811 | NP_722518 | 145389 | 1 | 0 | ||
| SLC38A7 | solute carrier family 38, member 7 | NM_018231 | NP_060701 | 55238 | 1 | 0 | |||
| SLC38A8 | solute carrier family 38, member 8 | NM_001080442 | NP_001073911 | 146167 | 1 | 0 | |||
| SLC38A9 | solute carrier family 38, member 9 | NM_173514 | NP_775785 | 153129 | 1 | 0 | |||
| SLC38A10 | solute carrier family 38, member 10 | NM_138570 | NP_612637 | 124565 | 3 | 0 | |||
| SLC38A11 | solute carrier family 38, member 11 | NM_173512 | NP_775783 | 151258 | 1 | 0 | |||
| SLC39A1 | solute carrier family 39 (zinc transporter), member 1 | ZIP1 | 604740 | NM_014437 | NP_055252 | 27173 | 1 | 0 | |
| SLC39A2 | solute carrier family 39 (zinc transporter), member 2 | ZIP2 | 612166 | NM_014579 | NP_055394 | 29986 | 1 | 0 | |
| SLC39A3 | solute carrier family 39 (zinc transporter), member 3 | ZIP3 | 612168 | NM_144564 | NP_653165 | 29985 | 2 | 0 | |
| SLC39A4 | solute carrier family 39 (zinc transporter), member 4 | ZIP4 | 607059 | Acrodermatitis ehteropathica | NM_017767 | NP_060237 | 55630 | 2 | 0 |
| SLC39A5 | solute carrier family 39 (metal ion transporter), member 5 | ZIP5 | 608730 | NM_173596 | NP_775867 | 283375 | 1 | 0 | |
| SLC39A6 | solute carrier family 39 (zinc transporter), member 6 | LIV-1 | 608731 | NM_001099406 | NP_001092876 | 25800 | 2 | 0 | |
| SLC39A7 | solute carrier family 39 (zinc transporter), member 7 | KE4 | 601416 | NM_001077516 | NP_001070984 | 7922 | 2 | 0 | |
| SLC39A8 | solute carrier family 39 (zinc transporter), member 8 | LZT-Hs6 | 608732 | NM_022154 | NP_071437 | 64116 | 1 | 0 | |
| SLC39A9 | solute carrier family 39 (zinc transporter), member 9 | FLJ11274 | NM_018375 | NP_060845 | 55334 | 1 | 0 | ||
| SLC39A10 | solute carrier family 39 (zinc transporter), member 10 | LZT-Hs2 | 608733 | NM_001127257 | NP_001120729 | 57181 | 2 | 0 | |
| SLC39A11 | solute carrier family 39 (metal ion transporter), member 11 | C17orf26 | NM_139177 | NP_631916 | 201266 | 1 | 0 | ||
| SLC39A12 | solute carrier family 39 (zinc transporter), member 12 | FLJ30499 | 608734 | NM_152725 | NP_689938 | 221074 | 1 | 0 | |
| SLC39A13 | solute carrier family 39 (zinc transporter), member 13 | FLJ25785 | 608735 | NM_001128225 | NP_001121697 | 91252 | 2 | 0 | |
| SLC39A14 | solute carrier family 39 (zinc transporter), member 14 | LZT-Hs4 | 608736 | NM_001128431 | NP_001121903 | 23516 | 2 | 0 | |
| SLC40A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 3 | IREG1 | 604653 | Hemochromatosis, type 4 | NM_014585 | NP_055400 | 30061 | 1 | 9 |
| SLC41A1 | solute carrier family 41, member 1 | MgtE | 610801 | NM_173854 | NP_776253 | 254428 | 1 | 0 | |
| SLC41A2 | solute carrier family 41, member 2 | SLC41A1-L1 | 610802 | NM_032148 | NP_115524 | 84102 | 1 | 0 | |
| SLC41A3 | solute carrier family 41, member 3 | SLC41A1-L2 | 610803 | NM_001008485 | NP_001008485 | 54946 | 4 | 0 | |
| SLC43A1 | solute carrier family 43, member 1 | 603733 | NM_003627 | NP_003618 | 8501 | 1 | 0 | ||
| SLC43A2 | solute carrier family 43, member 2 | 610791 | NM_152346 | NP_689559 | 124935 | 1 | 0 | ||
| SLC43A3 | solute carrier family 43, member 3 | NM_017611 | NP_060081 | 29015 | 3 | 0 | |||
| SLC44A1 | solute carrier family 44, member 1 | 606105 | NM_080546 | NP_536856 | 23446 | 1 | 0 | ||
| SLC44A2 | solute carrier family 44, member 2 | 606106 | NM_020428 | NP_065161 | 57153 | 2 | 0 | ||
| SLC44A3 | solute carrier family 44, member 3 | NM_152369 | NP_689582 | 126969 | 2 | 0 | |||
| SLC44A4 | solute carrier family 44, member 4 | 606107 | NM_025257 | NP_079533 | 80736 | 1 | 0 | ||
| SLC44A5 | solute carrier family 44, member 5 | NM_152697 | NP_689910 | 204962 | 2 | 0 | |||
| SLC45A1 | solute carrier family 45, member 1 | 605763 | NM_001080397 | NP_001073866 | 50651 | 1 | 0 | ||
| SLC45A2 | solute carrier family 45, member 2 | 606202 | NM_016180 | NP_057264 | 51151 | 2 | 0 | ||
| SLC45A3 | solute carrier family 45, member 3 | 605097 | NM_033102 | NP_149093 | 85414 | 1 | 0 | ||
| SLC45A4 | solute carrier family 45, member 4 | NM_001080431 | NP_001073900 | 57210 | 1 | 0 | |||
| SLC46A1 | solute carrier family 46 (folate transporter), member 1 | 611672 | NM_080669 | NP_542400 | 113235 | 1 | 0 | ||
| SLC46A2 | solute carrier family 46, member 2 | 608956 | NM_033051 | NP_149040 | 57864 | 1 | 0 | ||
| SLC46A3 | solute carrier family 46, member 3 | NM_181785 | NP_861450 | 283537 | 2 | 0 | |||
| SLC47A1 | MATE1 | 609832 | NM_018242 | NP_060712 | 55244 | 1 | 16 | ||
| SLC47A2 | 609833 | NM_152908 | NP_690872 | 146802 | 2 | 0 | |||
| SLCO1A2 | solute carrier organic anion transporter family, member 1A2 | OATPA | 602883 | NM_021094 | NP_066580 | 6579 | 3 | 15 | |
| SLCO1B1 | solute carrier organic anion transporter family, member 1B1 | OATPC | 604843 | NM_006446 | NP_006437 | 10599 | 1 | 19 | |
| SLCO1B3 | solute carrier organic anion transporter family, member 1B3 | OATP8 | 605495 | NM_019844 | NP_062818 | 28234 | 1 | 6 | |
| SLCO1C1 | solute carrier organic anion transporter family, member 1C1 | OATPF | NM_017435 | NP_059131 | 53919 | 1 | 1 | ||
| SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | SLCO2A1 | 601460 | NM_005630 | NP_005621 | 6578 | 1 | 0 | |
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | OATPB | 604988 | NM_007256 | NP_009187 | 11309 | 1 | 11 | |
| SLCO3A1 | solute carrier organic anion transporter family, member 3A1 | OATPD | NM_013272 | NP_037404 | 28232 | 1 | 7 | ||
| SLCO4A1 | solute carrier organic anion transporter family, member 4A1 | OATPE | NM_016354 | NP_057438 | 28231 | 1 | 0 | ||
| SLCO4C1 | solute carrier organic anion transporter family, member 4C1 | OATPH | 609013 | NM_180991 | NP_851322 | 353189 | 1 | 1 | |
| SLCO5A1 | solute carrier organic anion transporter family, member 5A1 | OATPJ | NM_030958 | NP_112220 | 81796 | 1 | 1 | ||
| SLCO6A1 | solute carrier organic anion transporter family, member 6A1 | OATPY | NM_173488 | NP_775759 | 133482 | 1 | 1 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | TAP1 | 170260 | Peptide transporter psf1 polymorhpism; Tap1 deficiency, somatic | NM_000593 | NP_000584 | 6890 | 1 | 1 |
| TAP2 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) | TAP2 | 170261 | Peptide transporter psf2 polymorphism; Bare lymphocyte syndrome, type 1; Wegener-like granulomatosis | NM_000544 | NP_000535 | 6891 | 2 | 0 |
| TPH2 | 607478 | NM_173353 | NP_775489 | 121278 | 1 | 0 |
Transporter List
Copyright 2009, UCSF Pharmacogenetics of Membrane Transporters. All rights reserved.